Mefenorex

Molecular structure via molpic based on CDK

Conformer []

Conformer structure via 3Dmol.js

Physical properties []
Molecular mass	211.73 g/mol ^[1]
Predicted LogP	3.1 ^[1]

Structural Identifiers []
Molecular formula	C₁₂H₁₈ClN ^[1]
IUPAC name	N-(3-chloropropyl)-1-phenylpropan-2-amine ^[1]
SMILES	CC(CC1=CC=CC=C1)NCCCCl ^[1]
InChI	InChI=1S/C12H18ClN/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,8-10H2,1H3 ^[1]
InChIKey	XXVROGAVTTXONC-UHFFFAOYSA-N ^[1]

Mefenorex

Mefenorex (also known as K98M4N387W, N-(3-Chloropropyl)-α-methylphenethylamine, Phenethylamine, N-(3-chloropropyl)-α-methyl-, (3-chloropropyl)(1-phenylpropan-2-yl)amine, chloropropylamphetamine, 241-279-0, Mefenorex, (+)-, N-(3-Chloropropyl)-α-methylbenzeneethanamine, 85052999IT or n-(3-chloropropyl)-α-methylphenethylamine) is a prodrug and stimulant substance of the amphetamine class.

Chemistry

Stereochemistry []

Mefenorex is a racemic mixture of the enantiomers

Stereoisomers
(R)-Mefenorex (S)-Mefenorex

Pharmacology

Mefenorex acts as a prodrug for:

Active metabolites []
Amphetamine

Subjective effects []

Physical effects
Abnormal heartbeat Appetite suppression Dehydration Dry mouth Increased blood pressure Increased heart rate Increased libido Restless legs Shakiness Stamina enhancement Stimulation Teeth grinding Vasoconstriction

Cognitive effects
Analysis enhancement Cognitive euphoria Compulsive redosing Disinhibition Ego inflation Focus enhancement Increased music appreciation Mania Motivation enhancement Suggestibility suppression Thought acceleration Wakefulness

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 21777, Mefenorex. Accessed July 19, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/21777
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mefenorex. UNII: 7FT4O2NC8G. Global Substance Registration System. Accessed July 19, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7FT4O2NC8G

Anodyne